Mexico Uterine Cancer Market Size & Outlook, 2025-2033


Mexico Uterine Cancer Market Insights

  • As per Reed Intelligence insights, the Mexico Uterine Cancer Market stood at USD 178.64 Million in 2024 and is anticipated to grow to USD 278.18 Million by 2033.
  • The Mexico market is expected to advance at a CAGR of 5.08% from 2026 through 2033.
  • In 2024, Endometrial Adenocarcinoma accounted for the highest share of the By Type market size.
  • During the forecast period, Adenosquamous Carcinoma is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • In 2024, Mexico represented 2.85% of the overall global Uterine Cancer Market size.
  • United States is projected to lead the global Uterine Cancer Market size by 2033.
  • Across LATAM, Brazil is anticipated to hold the dominant position in market size by 2033.
  • Argentina is forecasted to expand at the fastest pace in LATAM, attaining USD 78.16 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 178.64 Million
Market Size In 2033 USD 278.18 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 5.08% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends